Adult hospitalized patients with cystic fibrosis commonly receive nebulized medications. For single-patient-use nebulizers that are cleaned after each use, there is infrequent nebulizer contamination (0%-11%) with only low numbers of epidemiologically important pathogens (less than 100 colony-forming units), and this contamination is similar after 24, 48, and 72 hours of use.

Download full-text PDF

Source
http://dx.doi.org/10.1086/678603DOI Listing

Publication Analysis

Top Keywords

single-patient-use nebulizers
8
frequency contamination
4
contamination single-patient-use
4
nebulizers time
4
time adult
4
adult hospitalized
4
hospitalized patients
4
patients cystic
4
cystic fibrosis
4
fibrosis commonly
4

Similar Publications

Rationale: The American Thoracic Society guidelines for methacholine testing for the diagnosis of asthma recommends the 2-minute tidal breathing protocol with the Wright nebulizer, which produces more aerosol than required, generates a small particle size, and requires cleaning between tests.

Objectives: To evaluate methacholine testing using a disposable, breath-actuated AeroEclipse II, which produces aerosol during inspiration and was developed for single-patient use.

Methods: Forty-six adult subjects with asthma (19 men), aged 27.

View Article and Find Full Text PDF

Adult hospitalized patients with cystic fibrosis commonly receive nebulized medications. For single-patient-use nebulizers that are cleaned after each use, there is infrequent nebulizer contamination (0%-11%) with only low numbers of epidemiologically important pathogens (less than 100 colony-forming units), and this contamination is similar after 24, 48, and 72 hours of use.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!